Employment Verification for FibroGen.

About FibroGen

FibroGen is a biopharmaceutical company founded in 1993 and based in San Francisco, California, that develops and commercializes innovative therapies for the treatment of serious unmet medical needs. The company’s focus is on areas of high unmet medical needs with a particular emphasis on fibrosis, a pathological condition characterized by the development of excessive scar tissue in response to injury or disease. FibroGen’s lead product candidates include roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase enzymes that is in Phase III clinical development for the treatment of anemia in both chronic kidney disease and myelodysplastic syndrome patients. The company’s other clinical stage product candidates include pamrevlumab, a monoclonal antibody that targets connective tissue growth factor, and FG-5200, an orally-administered inhibitor of integrins alpha-4 and alpha-5. The company has collaborated with several pharmaceutical and biotechnology companies, including Astellas, AstraZeneca, and Boehringer Ingelheim, to develop and commercialize its product candidates. FibroGen is committed to the pursuit of scientific excellence and the development of innovative therapies that can improve the lives of patients.

The information on this page is not an endorsement of Truv’s services by FibroGen and is meant to be purely informational.

Verify FibroGen Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.